A Concerning Trend in Geriatric Pharmacy Merits Evidence-Based Intervention
The effects of polypharmacy on geriatric populations are an emerging concern that merits more exploration. The primary goal of this review was to evaluate the current body of knowledge on polypharmacy and explore the preventive and corrective measures to avoid negative outcomes. Even if a medication has an appropriate indication, polypharmacy in the geriatric population is associated with an increased risk of drug-drug or drug-condition interactions. Recent efforts to prevent polypharmacy include the development of interprofessional teams in clinics dedicated to medication review and reconciliation, deprescription plans aimed to safely discontinue potentially inappropriate medications, and inpatient screening tools that provide prescribing recommendations. In conclusion, polypharmacy affects a high percentage of the geriatric population. Current efforts to address and prevent polypharmacy are ongoing but have not been widely adopted.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
North Texas Division Allied Health Orientation Review and Attestation
Please click "TAKE COURSE" to beginThank you for your interest in a clinical rotation at Baylor Scott & White Health in our Central Texas Division! Before you can begin your experience with us, you must complete Allied Health Student Orientation.
Category
Format
  • Self-study / Enduring
Credits
2022 Acute and Chronic Pain Management and Opioid Prescribing for Outpatients - [IEM-X]
Acute and Chronic Pain Management and Opioid Prescribing for Outpatients is designed for providers to learn evidence-based treatment of pain, which will result in reduced long-term opioid prescribing and increased use of multimodal, multidisciplinary treatment for chronic pain.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit
  • Attendance
Optimal Cardiovascular Medical Therapy: Current Guidelines and New Developments
Coronary artery disease is a leading cause of mortality worldwide, and patients with obstructive coronary artery disease require optimal cardiovascular medical therapy along with lifestyle modification for secondary prevention of future cardiac events. Optimal medical therapy includes antiplatelet agents, high-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, aldosterone antagonists, and calcium channel blockers. There are differences in the medical therapy guidelines of the American Heart Association/American College of Cardiology and the European Society of Cardiology. In addition, there are emerging medical therapies that may be added to future guidelines with additional cardiovascular outcome benefits.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
Central Texas Division Allied Health Orientation Review and Attestation
Please click "TAKE COURSE" to begin
Category
Format
Credits

Pages